SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,584.84 71.29
(0.14%)

Dow Jones

7,519.91 78.81
(1.06%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.51 -0.04
(-0.04%)

EUR-INR

109.43 -0.23
(-0.21%)

GBP-INR

126.51 -0.33
(-0.26%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

391.1437121

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

34.51

83812.58

EPS(TTM)

Face Value()

Div & Yield %

41.81

0.28

Back

nippon life india asset management ltd

Maharashtra Corporation reports standalone net loss of Rs 0.04 crore in the December 2025 quarter

Feb 11,2026

Net loss of Maharashtra Corporation reported to Rs 0.04 crore in the quarter ended December 2025 as against net profit of Rs 0.40 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 0.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0	0.65	-100
OPM %	0	66.15	-
PBDT	-0.01	0.43	PL
PBT	-0.04	0.40	PL
NP	-0.04	0.40	PL

76,802.90 -607.08 ( -0.78%)

51,584.84 71.29 (0.14%)

7,519.91 78.81 (1.06%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.51 -0.04 (-0.04%)

109.43 -0.23 (-0.21%)

126.51 -0.33 (-0.26%)

0.59 0.00 (-0.05%)